Cargando…
The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
OBJECTIVES: There remains ongoing debate regarding the relative efficacy of public (NIH) and private sector funding in bringing biopharmaceutical innovations to market. This paper investigates the significance of each party’s level of funding for obtaining Food and Drug Administration (FDA) authoriz...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440766/ https://www.ncbi.nlm.nih.gov/pubmed/36057746 http://dx.doi.org/10.1007/s43441-022-00451-8 |